Hidradenitis Suppurativa and Treatments
Hidradenitis Suppurativa and Treatments is a research topic within Dermatology. Science Explorer counts 6.4k research works in it since 1950. 10.3% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the treatment, pathogenesis, and comorbidities of Hidradenitis Suppurativa (HS), also known as Acne Inversa. It covers topics such as inflammatory pathways, genetic susceptibility, metabolic syndrome, and the impact of HS on quality of life. The cluster also discusses various therapeutic approaches including immunosuppressive therapy and TNF-alpha inhibitors.
- Hidradenitis Suppurativa
- Acne Inversa
- Inflammatory Pathways
- Tumour Necrosis Factor
- IL-17 Serum Levels
- Metabolic Syndrome
- Notch Signaling
- Genetic Susceptibility
- Quality of Life
- Immunosuppressive Therapy
- Research works
- 6.4k fractional, since 1950
- In the world top 10%
- 661 per year above
- Top-10% rate
- 10.3% share of its works in the world top 10%
- Growth, 2018-21 → 2022-25
- +61% the tick is no change
- Largest producer
United States
45% of the 10 largest, 2022-now
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Hidradenitis Suppurativa and Treatments research?
By volume, the United States and China publish the most (792 and 200 works in 2022-now).
By volume, 2022-now
- 1
United States 792 works
- 2
China 200 works
- 3
Italy 127 works
- 4
Germany 112 works
- 5
Spain 106 works
- 6
Türkiye 97 works
- 7
United Kingdom 91 works
- 8
India 88 works
- 9
Canada 80 works
- 10
France 76 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Hidradenitis Suppurativa and Treatments research?
By volume in 2022-now, Harvard University publishes the most Hidradenitis Suppurativa and Treatments research, followed by University of Toronto and University of Copenhagen.
By volume, 2022-now
- 1
Harvard University
United States 39 works
- 2
University of Toronto
Canada 27 works
- 3
University of Copenhagen
Denmark 20 works
- 4
University of Miami
United States 19 works
- 5
University of North Carolina at Chapel Hill
United States 19 works
- 6
Mayo Clinic
United States 18 works
- 7
University of California, San Francisco
United States 17 works
- 8
Wake Forest University
United States 14 works
- 9
Stanford University
United States 14 works
- 10
University of Alabama at Birmingham
United States 12 works
Where is Hidradenitis Suppurativa and Treatments research done?
The largest centres of Hidradenitis Suppurativa and Treatments research in 2022-now are New York (United States), Boston (United States), London (United Kingdom) and Beijing (China).
Largest cities, 2022-now
- 1
New York
United States 39 works
- 2
Boston
United States 34 works
- 3
London
United Kingdom 31 works
- 4
Beijing
China 30 works
- 5
Toronto
Canada 28 works
- 6
Los Angeles
United States 25 works
- 7
Paris
France 25 works
- 8
Istanbul
Türkiye 25 works
- 9
Shanghai
China 24 works
- 10
Copenhagen
Denmark 22 works
Where is the best place to study Hidradenitis Suppurativa and Treatments?
Among universities, judged by research, Harvard University, University of Copenhagen and University of Naples Federico II score highest, combining citation excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the first ten of the table below, at the default weights. The upper left is the interesting corner: small places doing unusually strong work.
Universities only. The score blends citation excellence (40%), size (30%), specialisation (10%), growth (10%), international reach (10%), 2022-now; growth compares 2018-21 with 2022-25 and counts up to +20%, since a jump from a small base is mostly noise.
Every institution in Hidradenitis Suppurativa and Treatments, country by countryIs Hidradenitis Suppurativa and Treatments research growing?
Output in 2022-2025 was 61% higher than in 2018-2021, peaking in 2025. The fastest-growing topics are Hidradenitis Suppurativa and Treatments.
The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.
Its share of all research
Growing output can still be a shrinking share: all of science grows. This is Hidradenitis Suppurativa and Treatments as a percentage of every work published that year, 0.0097% in 2024.
Fractional works of Hidradenitis Suppurativa and Treatments over all fractional works that year. How the balance of science has shifted.
How much of it reaches the world top 10%
Year by year.
Of each year's works in it, the share that reached the world's 10% most cited for their field and year. A field is the world for its own topics, so there is no other line to hold it against.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.
Discussion
Ask a question or share a note about Hidradenitis Suppurativa and Treatments. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.